EW
GILD icon

Evoke Wealth’s Gilead Sciences GILD Stock Holding History

Evoke Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,909
Closed -$406K – 251
2026
Q1 		$406K Sell
2,909
-1,111
-28% -$156K 0.01% 462
2025
Q4 		$493K Buy
4,020
+459
+13% +$55.8K 0.01% 393
2025
Q3 		$395K Buy
3,561
+170
+5% +$19.3K 0.01% 427
2025
Q2 		$376K Buy
+3,391
New +$361K 0.01% 404
2022
Q4 		– Sell
-1,197
Closed -$74K – 681
2022
Q3 		$74K Buy
1,197
+31
+3% +$1.96K ﹤0.01% 461
2022
Q2 		$72K Sell
1,166
-317
-21% -$19.6K ﹤0.01% 453
2022
Q1 		$88K Buy
1,483
+238
+19% +$15.2K ﹤0.01% 449
2021
Q4 		$90K Buy
1,245
+2
+0.2% +$138 ﹤0.01% 462
2021
Q3 		$86K Sell
1,243
-7
-0.6% -$492 ﹤0.01% 447
2021
Q2 		$86K Sell
1,250
-7
-0.6% -$467 ﹤0.01% 460
2021
Q1 		$81K Sell
1,257
-54
-4% -$3.48K ﹤0.01% 401
2020
Q4 		$76K Buy
1,311
+681
+108% +$41.1K 0.01% 323
2020
Q3 		$40K Sell
630
-321
-34% -$22.3K ﹤0.01% 388
2020
Q2 		$73K Buy
951
+260
+38% +$19.9K 0.01% 311
2020
Q1 		$51.7K Sell
691
-2,110
-75% -$146K 0.01% 341
2019
Q4 		$182K Buy
2,801
+97
+4% +$6.32K 0.02% 234
2019
Q3 		$171K Buy
+2,704
New +$177K 0.02% 280

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Evoke Wealth's GILD Position: Q2 2026 in Review

Evoke Wealth sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 2,909 shares — an estimated $406K sold.

Evoke Wealth first reported a position in GILD in Q3 2019 and held it in 17 quarters. The position peaked at $493K in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Evoke Wealth reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 2,909 Gilead Sciences shares in Q2 2026, an estimated $406K.
  • Evoke Wealth first reported a position in Gilead Sciences in Q3 2019 and held it in 17 quarters.
  • Evoke Wealth's Gilead Sciences position peaked at $493K in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.